Nizal S. Chandrakumar

Array ( [id] => 5085910 [patent_doc_number] => 20070275961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Triazolo \' 1, 5-A ! Pyrimidines and Their Use in Medicine' [patent_app_type] => utility [patent_app_number] => 10/558694 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8826 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275961.pdf [firstpage_image] =>[orig_patent_app_number] => 10558694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820732 [patent_doc_number] => 07408065 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'P2X7 receptor antagonists and their use' [patent_app_type] => utility [patent_app_number] => 10/558898 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51838 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/408/07408065.pdf [firstpage_image] =>[orig_patent_app_number] => 10558898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4555537 [patent_doc_number] => 07820837 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Condensed ring compound' [patent_app_type] => utility [patent_app_number] => 10/558846 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39306 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820837.pdf [firstpage_image] =>[orig_patent_app_number] => 10558846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239643 [patent_doc_number] => 07592360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => '3-fluoro-piperidines as NMDA/NR2B antagonists' [patent_app_type] => utility [patent_app_number] => 10/559153 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9253 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592360.pdf [firstpage_image] =>[orig_patent_app_number] => 10559153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786951 [patent_doc_number] => 20060205847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Lactone-added hindered amine compound' [patent_app_type] => utility [patent_app_number] => 10/558177 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5607 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205847.pdf [firstpage_image] =>[orig_patent_app_number] => 10558177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6944404 [patent_doc_number] => 20050196453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Crystalline composition containing escitalopram' [patent_app_type] => utility [patent_app_number] => 10/851763 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5717 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196453.pdf [firstpage_image] =>[orig_patent_app_number] => 10851763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005642 [patent_doc_number] => 20070203214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Synthesis Of Chromanones' [patent_app_type] => utility [patent_app_number] => 10/557065 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13876 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203214.pdf [firstpage_image] =>[orig_patent_app_number] => 10557065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693887 [patent_doc_number] => 20070015799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Glyoxalase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/556901 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13583 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015799.pdf [firstpage_image] =>[orig_patent_app_number] => 10556901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7045619 [patent_doc_number] => 20050250214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Zinc binding compounds and their method of use' [patent_app_type] => utility [patent_app_number] => 10/840712 [patent_app_country] => US [patent_app_date] => 2004-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25287 [patent_no_of_claims] => 133 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250214.pdf [firstpage_image] =>[orig_patent_app_number] => 10840712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189208 [patent_doc_number] => 20070167517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Stabilized derivatives of ascorbic aicd' [patent_app_type] => utility [patent_app_number] => 10/553757 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5274 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167517.pdf [firstpage_image] =>[orig_patent_app_number] => 10553757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5113673 [patent_doc_number] => 20070197589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Cyclic quaternary amino derivatives as modulators of chemokine receptors' [patent_app_type] => utility [patent_app_number] => 10/552187 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11666 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197589.pdf [firstpage_image] =>[orig_patent_app_number] => 10552187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625930 [patent_doc_number] => 20060264435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 10/551783 [patent_app_country] => US [patent_app_date] => 2004-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31028 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264435.pdf [firstpage_image] =>[orig_patent_app_number] => 10551783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 44593 [patent_doc_number] => 07777056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Method for manufacture of 4-hydroxy pyran-2-one derivatives' [patent_app_type] => utility [patent_app_number] => 11/547533 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7440 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/777/07777056.pdf [firstpage_image] =>[orig_patent_app_number] => 11547533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5700741 [patent_doc_number] => 20060217426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Compound inhibiting in vivo phosphorous transport and medicine containing the same' [patent_app_type] => utility [patent_app_number] => 10/550857 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 185365 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217426.pdf [firstpage_image] =>[orig_patent_app_number] => 10550857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466690 [patent_doc_number] => 20040198750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Compositions useful as inhibitors of protein kinases' [patent_app_type] => new [patent_app_number] => 10/808678 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28082 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198750.pdf [firstpage_image] =>[orig_patent_app_number] => 10808678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5650009 [patent_doc_number] => 20060135744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Fluorinated cyclic compound, polymerizable fluoromonomer, fluoropolymer, resist material comprising the same, and method of forming pattern with the same' [patent_app_type] => utility [patent_app_number] => 10/553600 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11889 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135744.pdf [firstpage_image] =>[orig_patent_app_number] => 10553600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643271 [patent_doc_number] => 20060281726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Piperidine derivatives for the treatment of chemokine or h1 mediated disease state' [patent_app_type] => utility [patent_app_number] => 10/549868 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12652 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281726.pdf [firstpage_image] =>[orig_patent_app_number] => 10549868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5178101 [patent_doc_number] => 20070179161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Pyrazolopyrimidine compounds and their use in medicine' [patent_app_type] => utility [patent_app_number] => 10/551177 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11554 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179161.pdf [firstpage_image] =>[orig_patent_app_number] => 10551177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142340 [patent_doc_number] => 07687645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Intermediates for the preparation of citalopram and escitalopram' [patent_app_type] => utility [patent_app_number] => 10/550419 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6993 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687645.pdf [firstpage_image] =>[orig_patent_app_number] => 10550419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 817269 [patent_doc_number] => 07411077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Process for the preparation of a cyano-isobenzofuran' [patent_app_type] => utility [patent_app_number] => 10/549062 [patent_app_country] => US [patent_app_date] => 2004-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6241 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/411/07411077.pdf [firstpage_image] =>[orig_patent_app_number] => 10549062 [rel_patent_id] =>[rel_patent_doc_number] =>)